OsteoPhase

by Tango Advanced Nutrition

OsteoPhase
Nutritional Support for Osteoporosis and Calcium Dysregulation

OsteoPhase is the first nutritional formula designed to reliably regulate calcium homeostasis to rebuild skeletal bone and resolve calcium overload. Preliminary clinical findings indicate that OsteoPhase benefits osteoporosis, hyperglycemia and other disorders. These multiple effects support the hypothesis that the formulation regulates calcium homeostasis and merits evaluation for a wide variety of conditions.

Osteoporosis and Calcum Dysregulation

Osteoporosis, or porous bone, is a skeletal disease characterized by low bone mass and deterioration of the structure of bone tissue. Osteoporosis is marked by bone fragility and increased risk of fractures, especially of the hip, spine, and wrist.

Osteoporosis is not, however, an isolated disorder. The calcium lost from bone tissue floods and overloads body fluids and tissues. Because of the central role of calcium in all cell metabolism, this overload of calcium contributes to a multitude of other disorders. Researchers find that when calcium is deficient in skeletal bone, it is elevated in the blood and within tissue cells. While our bones become fragile and brittle, our arteries calcify, and our endocrine secretions, including insulin are disrupted. At the same time our muscle, nerve, and other cells lose function as they become overloaded with calcium.

The underlying mechanism that connects these disorders is loss of calcium ion homeostasis, or dysregulation of calcium ion flow. The problem of faulty calcium homeostasis is not solved by calcium supplementation, but by restoring proper regulation of calcium ion flow.

Clinical evaluation in China of OsteoPhase was based on a regulating dose of the formulation that contained less than 125 mg. per day of calcium. This level of calcium intake is far below the 1000 to 1500 mg. of daily calcium supplementation recommended by nutritionists and physicians in the US and elsewhere to protect against bone loss. This fact also supports the hypothesis that the formula achieves its results by calcium regulation and not by supplementation.

OsteoPhase is a marine-based nutritional product developed through ten years of research. The formula is a unique supplement made from Concha ostrea (Ostrea talienwhanensis – an oyster shell), Astragalus polysaccharides, Angelica sinensis root, and Coix seeds. All are common ingredients used for nutritional and therapeutic purposes in modern Chinese medicine. OsteoPhase is manufactured by a patented, high-tech process and contains ionic calcium (Ca2+), astragalus polysaccharides, 21 different amino acids, iron, zinc, and other biologically active molecules.

The ability of OsteoPhase to regulate calcium ion homeostasis is attributed to its unique ratio of ingredients and to a special manufacturing process developed at a marine medicine institute. The lead researcher at the institute identified biologically active proteins and enzymes from the inner lining of the oyster shell that are responsible for stimulating the formation of the shell from available calcium. He then developed a proprietary process for extracting these bioactive ingredients along with ionic calcium from the shell and combined them with three medicinal herbs that contribute to calcium regulation. The result of his work is the OsteoPhase formula, now available to men and women in the US that suffer from osteoporosis and the damage caused by the flooding of cells and soft tissues of calcium leached from bone tissue by various causes.